Morphological characteristics in peritoneum in patients with neutral peritoneal dialysis solution. (Q53609087)

16 May 2018

title

Morphological characteristics in peritoneum in patients with neutral peritoneal dialysis solution. (English)

1 reference

16 May 2018

0 references

1 reference

Chieko Hamada

1

1 reference

16 May 2018

Kazuho Honda

2

1 reference

16 May 2018

Kunio Kawanishi

3

1 reference

16 May 2018

Hirotaka Nakamoto

4

1 reference

16 May 2018

Yasuhiko Ito

5

1 reference

16 May 2018

Tsutomu Sakurada

6

1 reference

16 May 2018

Yudo Tanno

7

1 reference

16 May 2018

Toru Mizumasa

8

1 reference

16 May 2018

Masanobu Miyazaki

9

1 reference

16 May 2018

Misaki Moriishi

10

1 reference

16 May 2018

Masaaki Nakayama

11

1 reference

16 May 2018

publication date

14 February 2015

1 reference

16 May 2018

Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs

published in

1 reference

16 May 2018

volume

18

1 reference

16 May 2018

issue

3

1 reference

16 May 2018

page(s)

243-250

1 reference

16 May 2018

https://scigraph.springernature.com/pub.10.1007/s10047-015-0822-4

exact match

0 references

cites work

Impact of uremia, diabetes, and peritoneal dialysis itself on the pathogenesis of peritoneal sclerosis: a quantitative study of peritoneal membrane morphology

1 reference

https://api.crossref.org/works/10.1007%2FS10047-015-0822-4

Glucose degradation products (GDP's) and peritoneal changes in patients on chronic peritoneal dialysis: will new dialysis solutions prevent these changes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10047-015-0822-4

Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10047-015-0822-4

Advanced glycation end-products and peritoneal sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10047-015-0822-4

Peritoneal morphology after long-term peritoneal dialysis with biocompatible fluid: recent clinical practice in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10047-015-0822-4

Neutral solution low in glucose degradation products is associated with less peritoneal fibrosis and vascular sclerosis in patients receiving peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10047-015-0822-4

The role of peritoneal lavage and the prognostic significance of mesothelial cell area in preventing encapsulating peritoneal sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10047-015-0822-4

Biocompatible peritoneal dialysis solutions: do they indeed affect the outcome?

21 January 2018

1 reference

12 December 2020

Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds

1 reference

12 December 2020

Intracellular acidification mediates the inhibitory effect of peritoneal dialysate on peritoneal macrophages

1 reference

12 December 2020

Biocompatibility studies on peritoneal cells

1 reference

12 December 2020

Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH

1 reference

12 December 2020

3-Deoxyglucosone, a promoter of advanced glycation end products in fluids for peritoneal dialysis.

1 reference

12 December 2020

Quantitative evaluation and assessment of peritoneal morphologic changes in peritoneal dialysis patients

1 reference

12 December 2020

Impact of peritoneal dialysis solutions on peritoneal immune defense

1 reference

12 December 2020

2009 Japanese Society for Dialysis Therapy guidelines for peritoneal dialysis

1 reference

12 December 2020

Morphologic changes in the peritoneal membrane of patients with renal disease

1 reference

12 December 2020

Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis

1 reference

12 December 2020

10.1007/S10047-015-0822-4

Identifiers

DOI

1 reference

16 May 2018

PubMed ID

25680950

1 reference

16 May 2018